Theravance Biopharma
TBPH
TBPH
90 hedge funds and large institutions have $1.16B invested in Theravance Biopharma in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.31% more ownership
Funds ownership: 86.74% → 87.05% (+0.31%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
12% less capital invested
Capital invested by funds: $1.31B → $1.16B (-$152M)
Holders
90
Holding in Top 10
2
Calls
$2.66M
Puts
$383K
Top Buyers
| 1 | +$9.7M | |
| 2 | +$6.82M | |
| 3 | +$6.61M | |
| 4 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$3.68M |
| 5 |
Jane Street
New York
|
+$3.43M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$3.9M | |
| 3 | -$1.38M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$846K |
| 5 |
FAM
Foundation Asset Management
White Plains,
New York
|
-$800K |